BE Therapy (868378)

  https://cordis.europa.eu/project/id/868378

  Horizon 2020 (2014-2020)

  A revolutionary digital therapeutics platform for personalized and effective neurocognitive rehabilitation

  SME instrument (EIC-SMEInst-2018-2020)

  software  ·  public health  ·  physiotherapy  ·  business models  ·  stroke

  2019-06-01 Start Date (YY-MM-DD)

  2019-09-30 End Date (YY-MM-DD)

  € 71,429 Total Cost

  Description

Cognitive impairment causes decline in cognitive abilities, including memory and thinking skills. It is fast growing, and affects around 450 million people globally. The major causes of cognitive impairment are Traumatic Brain Injury (TBI), stroke, ageing, depression, anxiety and Attention-deficit/hyperactivity disorder (ADHD). Cognitive rehabilitation is a program to help brain-injured or otherwise cognitively impaired individuals to restore normal functioning, or to compensate for cognitive deficits. Nevertheless, the overall rehabilitation efficacy is surprisingly low (about 5%), even for patients with mild conditions. Multiple studies indicate that this stems from insufficient recruitment of patients’ brain engagement to the therapy. BE Therapy is a revolutionary digital therapeutics platform for personalised and effective neurocognitive rehabilitation. It consists of a wearable EEG device and a patient management system. During cognitive therapy, BE Therapy proprietary algorithms capture real-time brain engagement from EEG data. The patient management platform then autonomously adjusts the therapy to be most effective to the patient, maximizing brain engagement and dramatically improving cognitive therapy efficacy. This personalisation can be tweaked or supervised by an onsite or remote physician. Digitisation of the platform enables to optimise session frequencies and increase availability to serve more patients, thus maximising public health care system resources. Being a home-point-of-care solution, it reduces the costs and time associated with the rehabilitation. During the phase 1 feasibility study, Brainmarc will establish a sound go-to-market strategy and supply chain, and will outline further development plans. In the second phase of the innovation project, Brainmarc will optimize the device and treatment management system, perform clinical validation with European hospitals and rehabilitation centers, and obtain CE mark for market entry.

  Complicit Organisations

1 Israeli organisation participates in BE Therapy.